Health
Study addresses glycosylation concerns in SARS-CoV-2 vaccine design – News-Medical.Net
An international team of researchers has found that glycosylation patterns are conserved across the native spike protein of severe acute respiratory syndrome coronavirus…
An international team of researchers has found that glycosylation patterns are conserved across the native spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – and the recombinant spike proteins made in laboratories for use in vaccines.
The spike protein, which SARS-CoV-2 uses to bind to and infect cells, is the main target of neutralizing antibodies following natural infection with the virus or vaccination.
A…
-
Noosa News17 hours agoMan charged over allegedly abandoning Arnie the German shepherd in car after claiming dog and vehicle were stolen
-
Noosa News18 hours agoMotorcyclist dies in crash with truck
-
Noosa News19 hours agoSomerville House investigating after teachers’ dossier on students leaked
-
General24 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging